Anthropic says that Claude docs, slides and design are out of Beta and on every claude plan, including free
Newsquawk Staff ·
- Build live dashboards and animated explainers with Claude dashboards and claude motion, now in Beta.
- Claude dashboards is in beta on paid plans, and claude motion is in beta on team and enterprise plans.
What it means
This is a product availability announcement from a private company, so there is no listed equity to reprice directly; the read-through, if any, runs to the peer set of listed software and AI-exposed names rather than to the issuer itself. Feature graduations from beta to general availability, including extension to free tiers, are a standard cadence in consumer and enterprise software, and episodes of this kind have historically mattered less as standalone news than as markers in the competitive positioning between foundation model providers. The distinction worth drawing is between monetizable tiers (team and enterprise, where the new capabilities are gated) and the free tier, where broader access is primarily a distribution and user-acquisition play rather than an immediate revenue event. The follow-ons that typically carry signal in these cycles are pricing changes, enterprise contract disclosures, and usage metrics rather than feature announcements themselves. As a private issuer with no published financials, there is limited verifiable substance here beyond the product scope described, and precedent suggests such releases fade quickly absent a commercial or competitive escalation.
- US Equity Open: Software rout and Alphabet slump weigh on indices; Treasuries rally and metals slip
- Sell-side on Mag-7 names (Alphabet and Microsoft) post-earnings: GOOGL sees PT's lowered, while MSFT sees them lifted
- ADT (ADT) to be acquired by Thrive Holdings in a USD 15.3bln transaction; stockholders to receive USD 10/shr in cash, a 45.6% premium to the October 27th close
- US Broker Moves: GOOGL downgraded at Citizens; PYPL downgraded at Barclays
- Mastercard Incorporated (MA) Q3 2026 (USD): Adj. EPS 5.31 (exp. 5.17), Revenue 9.8bln (exp. 9.66bln)
Related headlines
- Microsoft (MSFT) looks to raise at least USD 25bln from USD bond sale, Bloomberg reports2 hours ago
- Merck (MRK) says, for Keytruda, expects moderating growth as it approaches peak revenues for certain approved indications and the German market to be impacted by policy dynamics3 hours ago
- DoorDash (DASH) Q3 2026 (USD): EPS 1.06 (exp. 0.81), revenue 4.6bln (exp. 4.56bln). Marketplace GOV 33.9bln3 hours ago
- DoorDash (DASH) to acquire Instacart (CART) for USD 65/shr, valuing the deal at USD 17bln3 hours ago
- Eli Lilly (LLY) says 7 out of 10 patients are choosing its obesity medicines through the government’s Medicare programme, according to a presentation3 hours ago
- Howmet Aerospace Inc. (HWM) Q3 2026 (USD): Adj. EPS 1.46 (exp. 1.37), Revenue 2.7bln (exp. 2.59bln); to increase share buyback by USD 5bln3 hours ago
- Altria Group Inc. (MO) Q3 2026 (USD): Adj. EPS 1.52 (exp. 1.51), Revenue 5.44bln (exp. 5.31bln); raises buyback by USD 1bln and raises FY26 earnings guidance3 hours ago
- Bristol-Myers Squibb Company (BMY) Q3 2026 (USD): Adj. EPS 1.35 (exp. 1.10), Revenue 13.07bln (exp. 12.72bln)3 hours ago
- Quanta Services Inc. (PWR) Q3 2026 (USD) Adj. EPS 6.06 (exp. 5.02), Revenue 12bln (exp. 11.03bln), says the long-term outlook for Quanta's business is positive3 hours ago
- Mobileye Global Inc. (MBLY) Q3 2026 (USD): EPS 0.11 (exp. 0.10), Revenue 492mln (exp. 477mln), Adj operating income 89mln (exp. 77.6mln), Current FY Rev. 1.99-2.02bln (exp. 2.01bln)4 hours ago
- Eli Lilly and Company (LLY) Q3 2026 (USD): adj. EPS 7.48 (exp. 5.68), Revenue 24.4bln (exp. 22.58bln); Mounjaro 10.7bln, Zepbound 5.3bln. Current FY Rev. 91-92bln (exp. 88.82bln)4 hours ago
- Caterpillar (CAT) Q3 Retail Statistics: Total Combined +22% (prev. +25%)4 hours ago
- Norwegian Cruise Line Holdings Ltd. (NCLH) Q3 2026 (USD): adj. EPS 1.12 (exp. 0.93), Revenue 2.9bln (exp. 2.88bln). Current FY adj. EPS 1.70 (exp. 1.54)4 hours ago
- Cognizant Technology Solutions (CTSH) Q3 2026 (USD): adj. EPS 1.49 (exp. 1.46), Revenue 5.7bln (exp. 5.64bln). Current FY Rev. 22.05-22.14bln (exp. 22.19bln)4 hours ago
- Merck & Co. Inc. (MRK) Q3 (USD) Adj. EPS 2.49 (exp. 2.09), Revenue 18.1bln (exp. 17.34bln), Current FY Adj EPS 2.77 (exp. 2.64), Current FY Rev. 66.8-67.3bln (exp. 67.05bln)4 hours ago